In 2022, the World Health Organization reported that more than 2.3 million people were newly diagnosed with breast cancer, and 670,000 people died worldwide. The higher number of incidences has been prevented due to the advancements in detection techniques and personalized, less aggressive treatment options for breast cancer. To avail this advance treatment, doctors prescribe Tucaxen 150mg Tablet for Breast Cancer treatment.
What should you know about Tucaxen Tablet?
This medicine has the active component Tucatinib. Studies show it offers successful outcomes in the treatment of patients with advanced or metastatic HER2-positive breast cancer. This is due to its ability to overcome the blood-brain barrier, its selectivity for the HER2 protein. And has higher effectiveness in combination therapies.
Which key factors support its strong therapeutic promise?
This medicine offers a major advantage because doctors can use it to treat HER2-positive breast cancer that has spread to the brain (brain metastases). This is an essential indication because it offers active treatment for involvement of the Central Nervous System. As a targeted kinase inhibitor, it selectively targets the abnormal protein which is overexpressed in certain cancer types. Hence blocks the signalling pathways that cause cancer cells to grow and divide.
Studies have shown that when used in combination with other medications, it improves the survival rates in patients with advanced cancers. Also beneficial for patients who have already received other HER2 targeted therapies. As an oral tablet it allows for a more convenient administration compared to intravenous treatments. Potentially increasing patient compliance and quality of life. Doctors prescribe this medication for patients who have already undergone one or more prior treatments. Thus, providing a new line of defence against treatment-resistant cancer.
Why is this medicine found to be HER2 selectivity?
It is the selectivity of Tucaxen that makes it so promising as a therapy. Unlike previous treatment that disrupts several receptors, this medicine targets the HER2 protein exclusively. It is because this medicine does not target any other receptors in the body. Therefore, this medicine has reduced the incidence of severe rashes and diarrhoea that existed in previous treatments. Patients can remain on this medication longer thereby maximising the amount of time they receive the benefits of the drug against their cancer.
Key side effects to be aware of
Being highly selective, this medicine can still cause certain side effects. The common side effects are diarrhoea, redness, swelling or pain on the hands & foot, fatigue, nausea etc. Some serious risks include severe diarrhoea, liver issues, yellowing of skin, dark urine etc. Doctors can manage these side effects through dose adjustments or supportive medications. If a patient experiences any severe risks, they should consult their doctor right away.
Conclusion
Therefore, the therapeutic promise of this medicine lies in its role as a highly selective HER2-targeted therapy. Its ability to effectively address breast cancer that has spread to the brain (brain metastases) is an exciting new advancement. Additionally, with early detection 99% of the patients will survive an additional five years or more. In order to get this treatment in affordable price, you can Buy Tucaxen 150mg Tablet at Globans Pharma website.
FAQs
How to take this medicine?
It is an oral tablet, usually taken twice daily. It can be taken with or without food, but it is important to take it at the same time every day to maintain consistent blood levels.
Is it effective for all breast cancers?
Doctors use it specifically to treat HER2-positive breast cancers. It will not be effective for any other type of breast cancer (HER2-negative or triple-negative breast cancers.
Tags : .....
